Olga Borges - Search Results

Year	Number of Results
2005	1
2006	1
2007	2
2008	2
2009	1
2010	2
2011	2
2012	3
2013	1
2015	2
2016	2
2017	4
2018	7
2019	9
2020	8
2022	2
2023	2
2024	5
2025	2

1

Editorial: Polymeric Nano-Biomaterials for Medical Applications: Advancements in Developing and Implementation Considering Safety-by-Design Concepts.

Borchard G, Som C, Zinn M, Ostafe V, Borges O, Perale G, Wick P. Borchard G, et al. Among authors: borges o. Front Bioeng Biotechnol. 2020 Oct 19;8:599950. doi: 10.3389/fbioe.2020.599950. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 33195175 Free PMC article. No abstract available.

2

Nasal Vaccines Against Hepatitis B: An Update.

Almeida MS, Borges O. Almeida MS, et al. Among authors: borges o. Curr Pharm Biotechnol. 2015;16(10):882-90. doi: 10.2174/1389201016666150505122422. Curr Pharm Biotechnol. 2015. PMID: 25941886 Review.

3

How the Lack of Chitosan Characterization Precludes Implementation of the Safe-by-Design Concept.

Marques C, Som C, Schmutz M, Borges O, Borchard G. Marques C, et al. Among authors: borges o. Front Bioeng Biotechnol. 2020 Mar 10;8:165. doi: 10.3389/fbioe.2020.00165. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 32211394 Free PMC article. Review.

4

Insights into Immune Exhaustion in Chronic Hepatitis B: A Review of Checkpoint Receptor Expression.

Costa JP, de Carvalho A, Paiva A, Borges O. Costa JP, et al. Among authors: borges o. Pharmaceuticals (Basel). 2024 Jul 21;17(7):964. doi: 10.3390/ph17070964. Pharmaceuticals (Basel). 2024. PMID: 39065812 Free PMC article. Review.

5

Glucan Particles: Choosing the Appropriate Size to Use as a Vaccine Adjuvant.

Colaço M, Panão Costa J, Borges O. Colaço M, et al. Among authors: borges o. Methods Mol Biol. 2022;2412:269-280. doi: 10.1007/978-1-0716-1892-9_13. Methods Mol Biol. 2022. PMID: 34918250

6

Hazard Assessment of Polymeric Nanobiomaterials for Drug Delivery: What Can We Learn From Literature So Far.

Jesus S, Schmutz M, Som C, Borchard G, Wick P, Borges O. Jesus S, et al. Among authors: borges o. Front Bioeng Biotechnol. 2019 Oct 23;7:261. doi: 10.3389/fbioe.2019.00261. eCollection 2019. Front Bioeng Biotechnol. 2019. PMID: 31709243 Free PMC article. Review.

7

Endotoxin contamination of nanoparticle formulations: A concern in vaccine adjuvant mechanistic studies.

Costa JP, Jesus S, Colaço M, Duarte A, Soares E, Borges O. Costa JP, et al. Among authors: borges o. Vaccine. 2023 May 26;41(23):3481-3485. doi: 10.1016/j.vaccine.2023.04.063. Epub 2023 Apr 28. Vaccine. 2023. PMID: 37121804 Free article.

8

Progress towards a needle-free hepatitis B vaccine.

Lebre F, Borchard G, de Lima MC, Borges O. Lebre F, et al. Among authors: borges o. Pharm Res. 2011 May;28(5):986-1012. doi: 10.1007/s11095-010-0314-4. Epub 2010 Nov 19. Pharm Res. 2011. PMID: 21088986 Review.

9

Mannose and Lactobionic Acid in Nasal Vaccination: Enhancing Antigen Delivery via C-Type Lectin Receptors.

Colaço M, Cruz MT, Almeida LP, Borges O. Colaço M, et al. Among authors: borges o. Pharmaceutics. 2024 Oct 8;16(10):1308. doi: 10.3390/pharmaceutics16101308. Pharmaceutics. 2024. PMID: 39458637 Free PMC article. Review.

10

Mucosal vaccines: recent progress in understanding the natural barriers.

Borges O, Lebre F, Bento D, Borchard G, Junginger HE. Borges O, et al. Pharm Res. 2010 Feb;27(2):211-23. doi: 10.1007/s11095-009-0011-3. Epub 2009 Dec 1. Pharm Res. 2010. PMID: 19953309 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51 results

Results by year